Tag: Combination
Digital Realty Completes Combination with InterXion

Digital Realty Completes Combination with InterXion

Strategic Transaction Establishes Combined Company as Leading Global Provider of Data Center Solutions with Enhanced Presence in Major European Metro Areas SAN FRANCISCO, ...

Lees verder
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcino

European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcino

Not intended for US, Canada and UK-based media -- EU approval based on JAVELIN Renal 101 trial results demonstrating significant improvement in progression-free survival with ...

Lees verder
Sirius Group Becomes Public Company Via Business Combination With Easterly Acquisition Corp.; Completes Private Placement; Announces New Majority

Sirius Group Becomes Public Company Via Business Combination With Easterly Acquisition Corp.; Completes Private Placement; Announces New Majority

-- Sirius Group is a global, multi-line insurance and reinsurance group founded in 1945 with over 1,800 clients in over 140 countries-- HAMILTON, Bermuda and NEW YORK, Nov. 5, ...

Lees verder
Sirius International Insurance Group, Ltd. To Become Public Company Through A Combination With Easterly Acquisition Corp. Sirius To Lend To Easte

Sirius International Insurance Group, Ltd. To Become Public Company Through A Combination With Easterly Acquisition Corp. Sirius To Lend To Easte

-- Proposed merger to result in Sirius Group becoming a publicly listed company -- -- Sirius Group is a global, multi-line insurance and reinsurance group with over 1,800 ...

Lees verder
4D pharma plc Enters Into Clinical Collaboration Agreement With MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and MRx0518 in Pat

4D pharma plc Enters Into Clinical Collaboration Agreement With MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and MRx0518 in Pat

LEEDS, England, June 7, 2018 /PRNewswire/ -- 4D pharma plc (AIM: DDDD) today announced an agreement with a subsidiary of MSD (tradename of Merck & Co., Inc., Kenilworth, ...

Lees verder
FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma

FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma

DARMSTADT, Germany and NEW YORK, December 21, 2017 /PRNewswire/ -- - Second Breakthrough Therapy Designation for avelumab in hard-to-treat cancer  - Renal ...

Lees verder
Combination Data for Lenvatinib and Pembrolizumab Demonstrate Notable Response Rates for Patients with Advanced Renal Cell Carcinoma

Combination Data for Lenvatinib and Pembrolizumab Demonstrate Notable Response Rates for Patients with Advanced Renal Cell Carcinoma

HATFIELD, England, September 9, 2017 /PRNewswire/ -- FOR EMEA MEDICAL MEDIA ONLY - NOT FOR SWISS/AUSTRIAN JOURNALISTS  - Updated results of advanced RCC cohort from ...

Lees verder
BizPress.nl